nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.0446	0.0465	CcSEcCtD
Nabilone—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0354	0.037	CcSEcCtD
Nabilone—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.031	0.0323	CcSEcCtD
Nabilone—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0292	0.0305	CcSEcCtD
Nabilone—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0276	0.0288	CcSEcCtD
Nabilone—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.0259	0.0271	CcSEcCtD
Nabilone—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.0259	0.0271	CcSEcCtD
Nabilone—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0213	0.0222	CcSEcCtD
Nabilone—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0207	0.0216	CcSEcCtD
Nabilone—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0212	CcSEcCtD
Nabilone—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0202	0.021	CcSEcCtD
Nabilone—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0203	CcSEcCtD
Nabilone—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0201	CcSEcCtD
Nabilone—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0201	CcSEcCtD
Nabilone—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0196	CcSEcCtD
Nabilone—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0166	CcSEcCtD
Nabilone—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0154	CcSEcCtD
Nabilone—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0154	CcSEcCtD
Nabilone—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.0144	0.015	CcSEcCtD
Nabilone—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.014	0.0146	CcSEcCtD
Nabilone—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0142	CcSEcCtD
Nabilone—Coma—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0139	CcSEcCtD
Nabilone—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0132	CcSEcCtD
Nabilone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0125	0.013	CcSEcCtD
Nabilone—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.012	0.0125	CcSEcCtD
Nabilone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0117	CcSEcCtD
Nabilone—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0116	CcSEcCtD
Nabilone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0108	CcSEcCtD
Nabilone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0108	CcSEcCtD
Nabilone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0106	CcSEcCtD
Nabilone—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.01	0.0105	CcSEcCtD
Nabilone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00999	0.0104	CcSEcCtD
Nabilone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00992	0.0104	CcSEcCtD
Nabilone—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00963	0.0101	CcSEcCtD
Nabilone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00933	0.00974	CcSEcCtD
Nabilone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00842	0.00879	CcSEcCtD
Nabilone—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00832	0.00869	CcSEcCtD
Nabilone—Depression—Riluzole—amyotrophic lateral sclerosis	0.0081	0.00846	CcSEcCtD
Nabilone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00792	0.00827	CcSEcCtD
Nabilone—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00767	0.008	CcSEcCtD
Nabilone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00726	0.00758	CcSEcCtD
Nabilone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00726	0.00758	CcSEcCtD
Nabilone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00724	0.00756	CcSEcCtD
Nabilone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00682	0.00712	CcSEcCtD
Nabilone—CNR1—N-cadherin signaling events—GRIA2—amyotrophic lateral sclerosis	0.00679	0.161	CbGpPWpGaD
Nabilone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00655	0.00683	CcSEcCtD
Nabilone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00652	0.0068	CcSEcCtD
Nabilone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00623	0.00651	CcSEcCtD
Nabilone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00617	0.00644	CcSEcCtD
Nabilone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00614	0.00641	CcSEcCtD
Nabilone—CNR1—N-cadherin signaling events—DCTN1—amyotrophic lateral sclerosis	0.00599	0.142	CbGpPWpGaD
Nabilone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00595	0.00621	CcSEcCtD
Nabilone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00615	CcSEcCtD
Nabilone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00613	CcSEcCtD
Nabilone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00609	CcSEcCtD
Nabilone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00573	0.00598	CcSEcCtD
Nabilone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00596	CcSEcCtD
Nabilone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00595	CcSEcCtD
Nabilone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00593	CcSEcCtD
Nabilone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00561	0.00586	CcSEcCtD
Nabilone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00558	0.00583	CcSEcCtD
Nabilone—Cough—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00579	CcSEcCtD
Nabilone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00574	CcSEcCtD
Nabilone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00572	CcSEcCtD
Nabilone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00564	CcSEcCtD
Nabilone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00564	CcSEcCtD
Nabilone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00564	CcSEcCtD
Nabilone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00562	CcSEcCtD
Nabilone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00558	CcSEcCtD
Nabilone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00529	0.00552	CcSEcCtD
Nabilone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00546	CcSEcCtD
Nabilone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00538	CcSEcCtD
Nabilone—Shock—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00532	CcSEcCtD
Nabilone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00528	CcSEcCtD
Nabilone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00523	CcSEcCtD
Nabilone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00516	CcSEcCtD
Nabilone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00506	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00493	CcSEcCtD
Nabilone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00489	CcSEcCtD
Nabilone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00486	CcSEcCtD
Nabilone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00482	CcSEcCtD
Nabilone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00481	CcSEcCtD
Nabilone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00476	CcSEcCtD
Nabilone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00451	0.0047	CcSEcCtD
Nabilone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00467	CcSEcCtD
Nabilone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00463	CcSEcCtD
Nabilone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00463	CcSEcCtD
Nabilone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00446	CcSEcCtD
Nabilone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00442	CcSEcCtD
Nabilone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00428	CcSEcCtD
Nabilone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00428	CcSEcCtD
Nabilone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00399	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.00376	0.0894	CbGpPWpGaD
Nabilone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00388	CcSEcCtD
Nabilone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00383	CcSEcCtD
Nabilone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0037	CcSEcCtD
Nabilone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00358	CcSEcCtD
Nabilone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00344	CcSEcCtD
Nabilone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00341	CcSEcCtD
Nabilone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00341	CcSEcCtD
Nabilone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00339	CcSEcCtD
Nabilone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00321	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00224	0.0532	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.0016	0.038	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00158	0.0376	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00126	0.03	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00126	0.0299	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00124	0.0295	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000988	0.0235	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000959	0.0228	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000951	0.0226	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000752	0.0179	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000691	0.0164	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000549	0.0131	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000542	0.0129	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000542	0.0129	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000492	0.0117	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000475	0.0113	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000431	0.0102	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000425	0.0101	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000418	0.00994	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000386	0.00917	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000383	0.00911	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000361	0.00857	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000342	0.00812	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000331	0.00787	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000328	0.0078	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000301	0.00715	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000294	0.00698	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000291	0.00691	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000283	0.00672	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000268	0.00637	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00026	0.00617	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000243	0.00577	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000236	0.00562	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000231	0.00548	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000228	0.00542	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000215	0.0051	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.0002	0.00474	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000191	0.00453	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000187	0.00445	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000186	0.00441	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000178	0.00424	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000169	0.004	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000157	0.00372	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000153	0.00363	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000147	0.00349	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000144	0.00341	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00014	0.00333	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000127	0.00301	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00012	0.00285	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000118	0.00281	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.00268	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.95e-05	0.00237	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.76e-05	0.00232	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.27e-05	0.0022	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.66e-05	0.00182	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.51e-05	0.00178	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.1e-05	0.00169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.37e-05	0.00151	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.89e-05	0.0014	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.57e-05	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5e-05	0.00119	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.82e-05	0.00114	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.78e-05	0.000898	CbGpPWpGaD
